Celltrion FDA warning causes headache for Teva's biologics ambition
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Pharma Receive Warning Letter - Parker Waichman LLP
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
Teva months from restarting production at Hungary plant banned by US FDA
Former FDA Inspector Speaks Out About Blood Pressure Medication Recall - Drug And Device Watch
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Surprise US FDA inspections: Cause for alarm? | Mint
Filling errors, counterfeit packs gain FDA's attention | Healthcare Packaging
Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. 4/5/17
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Lists Irvine Facilities; Industrial Redevelopment Likely - Orange County Business Journal
FDA Announces New Framework for Pharmaceutical Inspections | Packaging World
After Ignoring Letters From US FDA, Teva And Cipla Will Have ANDAs Withdrawn :: Pink Sheet
Teva puts the brakes on troubled California sterile injectables plant: reports | Fierce Pharma
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Cheap Prescription Drugs in U.S. Can Have Hidden Cost - Bloomberg
Teva recalls US-made drugs following contamination fears - The Boston Globe
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan | Teva, Radio, Difficult
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
Teva wants to join Big PhRMA with an ongoing FDA Import Alert for Deficient cGMP
